Skip to main content

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Why this differentiation matters

Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation.

---


1. Basic Definitions


Brugada ECG Pattern


Primary repolarization abnormality


Genetic sodium-channel disorder


Characteristic ST-segment elevation in V1–V3


Risk of ventricular fibrillation and sudden death



Incomplete RBBB (iRBBB)


Depolarization abnormality


Delay in right ventricular conduction


Common in healthy individuals


Usually asymptomatic and benign




---


2. ECG Morphology: Side-by-Side Comparison


QRS Duration


Brugada: QRS usually <120 ms


iRBBB: QRS <120 ms, but with RBBB morphology




---


V1–V2 Pattern (Key Differentiator)


Brugada


Pseudo-RBBB appearance


ST elevation ≥2 mm


ST segment is coved or saddleback


Terminal QRS blends into ST segment


r′ is broad, rounded, and slow



iRBBB


Classic rSr′ pattern


r′ is sharp and narrow


ST segment is isoelectric or minimal elevation


Clear separation between QRS and ST segment




---


ST-Segment Shape


Feature Brugada iRBBB


ST elevation Present (≥2 mm) Absent or minimal

Shape Coved / Saddleback Flat

J-point Elevated Normal




---


T-Wave Orientation


Brugada: T-wave inverted in V1–V2 (Type 1)


iRBBB: T-wave usually upright or mildly discordant




---


3. Brugada ECG Types (Only Type 1 is Diagnostic)


Type 1 (Diagnostic)


Coved ST elevation ≥2 mm


Downsloping ST


Inverted T-wave



Type 2


Saddleback ST elevation


r′ present


Not diagnostic alone



Type 3


Minimal ST elevation (<2 mm)


Non-diagnostic




---


4. Response to High Right Precordial Leads


Brugada


ST elevation increases when V1–V2 placed in 2nd–3rd intercostal space



iRBBB


No significant change with lead repositioning




---


5. Pharmacological Challenge (Specialist Setting)


Sodium channel blockers (ajmaline, flecainide, procainamide)



Brugada


Converts Type 2/3 → Type 1



iRBBB


No Brugada pattern unmasked




---


6. Clinical Context (Critical Clues)


Feature Brugada iRBBB


Syncope Common Rare

Sudden cardiac death Yes No

Family history of SCD Often present Absent

Fever-induced changes Yes No




---


7. Common Pitfalls


Calling pseudo-RBBB + ST elevation as iRBBB


Ignoring ST morphology and focusing only on rSr′


Failure to record high intercostal V1–V2 leads


Misinterpreting athletic or young adult ECGs




---


8. Practical Bedside Rule


If V1–V2 show r′ + ST elevation → think Brugada first, not iRBBB.

iRBBB should never have significant ST elevation.



---


9. Summary Table


Feature Brugada iRBBB


Pathophysiology Repolarization Depolarization

ST elevation Present Absent

ST shape Coved / Saddleback Flat

r′ morphology Broad, slow Sharp, narrow

Risk Sudden death Benign

Management Risk stratification ± ICD Reassurance




---


Take-Home Message


Incomplete RBBB is a conduction delay, Brugada is a lethal electrical disease. The ST segment, not the rSr′, is the key. When in doubt, treat the ECG as Brugada until proven otherwise. 




Comments

  1. I have read that inverted T-Waves are in V2, V3, V4 in Brugada - on PubMed F.i.. hmm..

    ReplyDelete

Post a Comment

Drop your thoughts here, we would love to hear from you

Popular posts from this blog

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...